These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 27471987

  • 1. Gender differences and bleeding complications after PCI on first and second generation DES.
    Wanha W, Kawecki D, Roleder T, Pluta A, Marcinkiewicz K, Morawiec B, Kret M, Pawlowski T, Smolka G, Ochala A, Wojakowski W.
    Scand Cardiovasc J; 2017 Feb; 51(1):53-60. PubMed ID: 27471987
    [Abstract] [Full Text] [Related]

  • 2. Impact of anaemia on long-term outcomes in patients treated with first- and second-generation drug-eluting stents; Katowice-Zabrze Registry.
    Wańha W, Kawecki D, Roleder T, Pluta A, Marcinkiewicz K, Dola J, Morawiec B, Krzych Ł, Pawłowski T, Smolka G, Ochała A, Nowalany-Kozielska E, Tendera M, Wojakowski W.
    Kardiol Pol; 2016 Feb; 74(6):561-9. PubMed ID: 26575311
    [Abstract] [Full Text] [Related]

  • 3. Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
    Giustino G, Harari R, Baber U, Sartori S, Stone GW, Leon MB, Windecker S, Serruys PW, Kastrati A, Von Birgelen C, Kimura T, Stefanini GG, Dangas GD, Wijns W, Steg PG, Morice MC, Camenzind E, Weisz G, Smits PC, Sorrentino S, Sharma M, Farhan S, Faggioni M, Kandzari D, Galatius S, Jeger RV, Valgimigli M, Itchhaporia D, Mehta L, Kim HS, Chieffo A, Mehran R.
    JAMA Cardiol; 2017 Aug 01; 2(8):855-862. PubMed ID: 28658478
    [Abstract] [Full Text] [Related]

  • 4. The Pt-Cr everolimus-eluting stent with bioabsorbable polymer in the treatment of patients with acute coronary syndromes. Results from the SYNERGY ACS registry.
    de la Torre Hernandez JM, Moreno R, Gonzalo N, Rivera R, Linares JA, Veiga Fernandez G, Gomez Menchero A, Garcia Del Blanco B, Hernandez F, Benito Gonzalez T, Subinas A, Escaned J.
    Cardiovasc Revasc Med; 2019 Aug 01; 20(8):705-710. PubMed ID: 30414798
    [Abstract] [Full Text] [Related]

  • 5. Clinical outcomes of different first- and second-generation drug-eluting stents in routine clinical practice: results from the prospective multicenter German DES.DE registry.
    Akin I, Hochadel M, Abdel-Wahab M, Senges J, Richardt G, Schneider S, Tebbe U, Kuck KH, Nienaber CA.
    Clin Res Cardiol; 2013 May 01; 102(5):371-81. PubMed ID: 23386256
    [Abstract] [Full Text] [Related]

  • 6. Three-year outcomes related to coronary stenting; a registry-based real-life population study.
    Piuhola J, Holmström LTA, Niemelä M, Kervinen K, Tulppo M, Asikainen R, Hypèn L, Junttila MJ.
    Scand Cardiovasc J; 2020 Jun 01; 54(3):162-168. PubMed ID: 31752551
    [Abstract] [Full Text] [Related]

  • 7. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
    Puymirat E, Mangiacapra F, Peace A, Ntarladimas Y, Conte M, Bartunek J, Vanderheyden M, Wijns W, de Bruyne B, Barbato E.
    Arch Cardiovasc Dis; 2013 Nov 01; 106(11):554-61. PubMed ID: 24231052
    [Abstract] [Full Text] [Related]

  • 8. Sustained risk of stent thrombosis and restenosis in first generation drug-eluting Stents after One Decade of Follow-up: A Report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Völz S, Angerås O, Odenstedt J, Ioanes D, Haraldsson I, Dworeck C, Redfors B, Råmunddal T, Albertsson P, Petursson P, Omerovic E.
    Catheter Cardiovasc Interv; 2018 Nov 15; 92(6):E403-E409. PubMed ID: 29745465
    [Abstract] [Full Text] [Related]

  • 9. Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: Results from the FAST-MI 2010 registry.
    Bailleul C, Aissaoui N, Cayla G, Dillinger JG, Jouve B, Schiele F, Ferrières J, Simon T, Danchin N, Puymirat E, FAST-MI investigators.
    Arch Cardiovasc Dis; 2018 Feb 15; 111(2):101-108. PubMed ID: 28939193
    [Abstract] [Full Text] [Related]

  • 10. Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry.
    Abe D, Sato A, Hoshi T, Maruta S, Misaki M, Kakefuda Y, Watabe H, Hiraya D, Sakai S, Kawabe M, Takeyasu N, Aonuma K.
    J Cardiol; 2014 Nov 15; 64(5):377-83. PubMed ID: 24685689
    [Abstract] [Full Text] [Related]

  • 11. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials.
    Sabaté M, Räber L, Heg D, Brugaletta S, Kelbaek H, Cequier A, Ostojic M, Iñiguez A, Tüller D, Serra A, Baumbach A, von Birgelen C, Hernandez-Antolin R, Roffi M, Mainar V, Valgimigli M, Serruys PW, Jüni P, Windecker S.
    JACC Cardiovasc Interv; 2014 Jan 15; 7(1):55-63. PubMed ID: 24332419
    [Abstract] [Full Text] [Related]

  • 12. Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes.
    Lettino M, Andell P, Zeymer U, Widimsky P, Danchin N, Bardaji A, Barrabes JA, Cequier A, Claeys MJ, De Luca L, Dörler J, Erlinge D, Erne P, Goldstein P, Koul SM, Lemesle G, Lüscher TF, Matter CM, Montalescot G, Radovanovic D, Sendón JL, Tousek P, Weidinger F, Weston CFM, Zaman A, Li J, Jukema JW, PIRAEUS group.
    Eur Heart J Cardiovasc Pharmacother; 2017 Oct 01; 3(4):198-213. PubMed ID: 28329196
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcomes following drug-eluting stents versus bare metal stents for primary percutaneous coronary intervention: A real-world analysis of 11,181 patients from the british columbia cardiac registry.
    Iqbal MB, Nadra IJ, Ding L, Fung A, Aymong E, Chan AW, Hodge S, Robinson SD, Siega AD, British Columbia Cardiac Registry Investigators.
    Catheter Cardiovasc Interv; 2016 Jul 01; 88(1):24-35. PubMed ID: 26945680
    [Abstract] [Full Text] [Related]

  • 14. Very late stent thrombosis with second generation drug eluting stents compared to bare metal stents: Network meta-analysis of randomized primary percutaneous coronary intervention trials.
    Philip F, Stewart S, Southard JA.
    Catheter Cardiovasc Interv; 2016 Jul 01; 88(1):38-48. PubMed ID: 26916633
    [Abstract] [Full Text] [Related]

  • 15. Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations.
    Magalhaes MA, Minha S, Chen F, Torguson R, Omar AF, Loh JP, Escarcega RO, Lipinski MJ, Baker NC, Kitabata H, Ota H, Suddath WO, Satler LF, Pichard AD, Waksman R.
    Circ Cardiovasc Interv; 2014 Dec 01; 7(6):768-76. PubMed ID: 25466551
    [Abstract] [Full Text] [Related]

  • 16. Comparison of First- and Second-Generation Drug-Eluting Stents in an All-Comer Population of Patients with Diabetes Mellitus (from Katowice-Zabrze Registry).
    Kawecki D, Morawiec B, Dola J, Wańha W, Smolka G, Pluta A, Marcinkiewicz K, Ochała A, Nowalany-Kozielska E, Wojakowski W.
    Med Sci Monit; 2015 Oct 27; 21():3261-9. PubMed ID: 26506478
    [Abstract] [Full Text] [Related]

  • 17. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
    Holmvang L, Kelbæk H, Kaltoft A, Thuesen L, Lassen JF, Clemmensen P, Kløvgaard L, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Tilsted HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Helqvist S.
    JACC Cardiovasc Interv; 2013 Jun 27; 6(6):548-53. PubMed ID: 23683734
    [Abstract] [Full Text] [Related]

  • 18. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
    Serruys PW, Farooq V, Kalesan B, de Vries T, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Wijns W, Morice MC, Di Mario C, Corti R, Antoni D, Sohn HY, Eerdmans P, Rademaker-Havinga T, van Es GA, Meier B, Jüni P, Windecker S.
    JACC Cardiovasc Interv; 2013 Aug 27; 6(8):777-89. PubMed ID: 23968698
    [Abstract] [Full Text] [Related]

  • 19. First- Versus Second-Generation Drug-Eluting Stents in Acute Coronary Syndromes (Katowice-Zabrze Registry).
    Kawecki D, Morawiec B, Dola J, Wanha W, Smolka G, Pluta A, Marcinkiewicz K, Ochała A, Nowalany-Kozielska E, Wojakowski W.
    Arq Bras Cardiol; 2016 May 27; 106(5):373-81. PubMed ID: 27058257
    [Abstract] [Full Text] [Related]

  • 20. Sex-related impact on clinical outcomes of patients treated with drug-eluting stents according to clinical presentation: Patient-level pooled analysis from the GRAND-DES registry.
    Shin ES, Jun EJ, Han JK, Kong MG, Kang J, Zheng C, Garg S, Choi YJ, Bae JW, Chun KJ, Kim DI, Rha SW, Lee SY, Rhew JY, Woo SI, Lee HC, Jeong JO, Yang HM, Park KW, Kang HJ, Koo BK, Chae IH, Kim HS.
    Cardiol J; 2023 May 27; 30(1):105-116. PubMed ID: 33634845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.